Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-1989 | 10-1988 | 07-1988 | 04-1988 | 01-1988 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 972 | 674 | 445 | 519 | 531 |
| TOTAL | $972 | $674 | $445 | $519 | $531 |
| Non-Current Assets | |||||
| PPE Net | 7,945 | 7,548 | 7,066 | 6,887 | 6,769 |
| Other Non-Current Assets | 5,016 | 5,127 | 5,756 | 6,084 | 6,181 |
| TOTAL | $12,961 | $12,675 | $12,822 | $12,971 | $12,950 |
| Total Assets | $13,933 | $13,349 | $13,267 | $13,490 | $13,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,060 | 0 | 247 | 89 | 95 |
| Accounts payable and accrued liabilities | 4,114 | 3,956 | 3,718 | 3,484 | 3,400 |
| Accrued Expenses | 3,775 | 1,833 | 2,266 | 1,982 | 2,090 |
| TOTAL | $8,949 | $8,003 | $6,928 | $6,123 | $7,099 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 645 | 623 | 515 | 514 | 445 |
| TOTAL | $1,503 | $1,425 | $1,248 | $1,207 | $1,096 |
| Total Liabilities | $10,452 | $9,428 | $8,176 | $7,330 | $8,195 |
| Shareholders' Equity | |||||
| Common Shares | 43 | 43 | 33 | 30 | 30 |
| Other shareholders' equity | -51 | -45 | -45 | 63 | 67 |
| TOTAL | $24,852 | $24,858 | $12,770 | $8,722 | $8,726 |
| Total Liabilities And Equity | $35,304 | $34,286 | $20,946 | $16,052 | $16,921 |